Fundraising Fox
3T Biosciences
South San Francisco, US · Founded 2017 · 24 employees on LinkedIn · 8 known investors
Find your way into 3T Biosciences
Sign up to see every warm intro you have to 3T Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 3T Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
Founders & leadership
3T Biosciences was founded in 2017 by K. Christopher Garcia and Marvin Gee.
Investors · 8
How we know: Asset Management Company's portfolio page · Not right? Tell us
How we know: collabfund.com · Not right? Tell us
How we know: CRV (Charles River Ventures)'s portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Westlake Village BioPartners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: cnbc.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Related companies · 2
Companies working in the same space as 3T Biosciences.
In the news
Frequently asked questions
- What does 3T Biosciences do?
- 3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
- Who founded 3T Biosciences?
- 3T Biosciences was founded by K. Christopher Garcia, Marvin Gee in 2017.
- Who are 3T Biosciences's investors?
- 3T Biosciences's investors include Asset Management Company, Collaborative Fund, CRV (Charles River Ventures), Westlake Village BioPartners, Menlo Ventures, OS Fund, Starlight Ventures, Thiel Capital.
- Where is 3T Biosciences headquartered?
- 3T Biosciences is headquartered in South San Francisco, US.